Mucocutaneous changes in patients with lupus erythematosus. The relationship of these lesions to systemic disease.
The gamut of cutaneous lesions, as well as the spectrum of systemic disease, has been better characterized. In this section, the relationship of the skin lesion to systemic disease is discussed. Also, the importance of a careful characterization of the skin lesion is stressed. The therapy of cutaneous LE is also discussed.
Callen
J P
JP
University of Louisville, Kentucky.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D005528:Foot; D006225:Hand; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy / Q000473:pathology*; D008179:Lupus Erythematosus, Discoid / Q000145:classification / Q000150:complications / Q000473:pathology*; D013473:Sunscreening Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D013473:Sunscreening Agents